| 1 | Graft versus leukemia. VI. Adoptive immunotherapy in combination with chemoradiotherapy for spontaneous leukemia-lymphoma in AKR mice. (Bortin MM, Rose WC, Truitt RL, Rimm AA, Saltzstein EC, Rodey GE) J Natl Cancer Inst 1975 Nov;55(5):1227-9 6 Citations |
| 1 | High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study. (Pole JG, Casper J, Elfenbein G, Gee A, Gross S, Janssen W, Koch P, Marcus R, Pick T, Shuster J) J Clin Oncol 1991 Jan;9(1):152-8 125 Citations |
| 1 | Preoperative chemoradiotherapy for adenocarcinoma of the pancreas. Rationale and technique. (Evans DB, Byrd DR, Mansfield PF) Am J Clin Oncol 1991 Aug;14(4):359-64 17 Citations |
| 1 | Preoperative chemoradiotherapy, pancreaticoduodenectomy, and external- beam intraoperative radiotherapy for pancreatic adenocarcinoma: The M.D. Anderson experience (Leach SD, Rich TA, Abbruzzese JL, Lee JE, Cleary KR, Katz RL, Charnsangavej C, Ames FC, Buchholz DJ, Fenoglio CJ, Stanford P, Evans DB) Cancer Bulletin 1994;46(6):518-524 3 Citations |
| 1 | Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. (Breslin TM, Hess KR, Harbison DB, Jean ME, Cleary KR, Dackiw AP, Wolff RA, Abbruzzese JL, Janjan NA, Crane CH, Vauthey JN, Lee JE, Pisters PW, Evans DB) Ann Surg Oncol 2001 Mar;8(2):123-32 332 Citations |
| 1 | Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence. (Singh AK, Grigsby PW, Rader JS, Mutch DG, Powell MA) Int J Radiat Oncol Biol Phys 2005 Feb 01;61(2):450-5 71 Citations |
| 1 | POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group. (Kung FH, Schwartz CL, Ferree CR, London WB, Ternberg JL, Behm FG, Wharam MD, Falletta JM, de Alarcon P, Chauvenet AR, Children's Oncology Group) J Pediatr Hematol Oncol 2006 Jun;28(6):362-8 81 Citations |
| 1 | Suxamethonium-induced hyperkalaemia 6 weeks after chemoradiotherapy in a patient with rectal carcinoma. (Holak EJ, Connelly JF, Pagel PS) Br J Anaesth 2007 Jun;98(6):766-8 7 Citations |
| 1 | Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms. (Stinchcombe TE, Gore EM) Oncologist 2010;15(2):187-95 94 Citations |
| 1 | Antitumor effects on primary tumor and metastatic lymph nodes by superselective intra-arterial concurrent chemoradiotherapy for oral cancer. (Uehara M, Shiraishi T, Tobita T, Nonaka M, Asahina I) Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010 Aug;110(2):172-7 8 Citations |
| 4 | Prognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy. (Bedi M, King DM, Shivakoti M, Wang T, Zambrano EV, Charlson J, Hackbarth D, Neilson J, Whitfield R, Wang D) Radiat Oncol 2013 Mar 14;8:60 24 Citations |
| 1 | Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus. (Toh E, Wilson J, Sebag-Montefiore D, Botterill I) Colorectal Dis 2014 Mar;16(3):O90-7 34 Citations |
| 1 | The management of patients with esophageal cancer and coronary artery stenosis undergoing radiotherapy or concurrent chemoradiotherapy: a single-center experience. (Luo H, Chen X, Zhang Q, Wang L, Qiao L, Liang N, Xie J, Yu X, Song M, Liu Z, Lv Y, Liu F, Tian Y, Cheng J, Deng G, Zhang J, Li XA, Zhang J) J BUON 2016;21(2):419-26 1 Citation |
| 1 | Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839. (Edelman MJ, Hu C, Le QT, Donington JS, D'Souza WD, Dicker AP, Loo BW, Gore EM, Videtic GMM, Evans NR, Leach JW, Diehn M, Feigenberg SJ, Chen Y, Paulus R, Bradley JD) J Thorac Oncol 2017 Sep;12(9):1413-1420 19 Citations |
| 1 | Smoking is predictive of poorer distant metastasis-free and progression free-survival in soft tissue sarcoma patients treated with pre-operative radiotherapy or chemoradiotherapy. (Gannon NP, King DM, Bedi M) Clin Sarcoma Res 2018;8:7 |
| 1 | An Economic Analysis of Radiation Therapy Oncology Group 94-10: Cost-Efficacy of Concurrent vs. Sequential Chemoradiotherapy. (Konski A, Bhargavan M, Owen J, Komaki R, Langer CJ, Gore E, Paulus R, Choy H, Bruner DW, Curran WJ) J Radiat Oncol 2018 Jun;7(2):195-201 |
| 1 | Pathologic necrosis following neoadjuvant radiotherapy or chemoradiotherapy is prognostic of poor survival in soft tissue sarcoma. (Gannon NP, Stemm MH, King DM, Bedi M) J Cancer Res Clin Oncol 2019 May;145(5):1321-1330 31 Citations |
| 1 | Comment on De Felice et al, "Intensified Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer in Elderly Patients: Toxicity, Disease Control, and Survival Outcomes". (Yavas G, Yavas C) Clin Colorectal Cancer 2019 Dec;18(4):e368-e369 1 Citation |
| 1 | Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy. In regard to Vojtíšek et al. (Onal C, Yavas G, Yavas C) Strahlenther Onkol 2021 Oct;197(10):935-936 |
| 1 | The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy. (Onal C, Gultekin M, Yavas G, Oymak E, Yuce Sari S, Guler OC, Yigit E, Yildiz F) J Obstet Gynaecol 2022 Aug;42(6):2426-2432 8 Citations |
| 1 | An Exploratory Study of Neoadjuvant Cetuximab Followed by Cetuximab and Chemoradiotherapy in Women With Newly Diagnosed Locally Advanced Cervical Cancer. (Fracasso PM, Duska LR, Thaker PH, Gao F, Zoberi I, Dehdashti F, Siegel BA, Uliel L, Menias CO, Rehm PK, Goodner SA, Creekmore AN, Lothamer HL, Rader JS) Am J Clin Oncol 2022 Jul 01;45(7):286-293 5 Citations |
| 1 | Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study. (Guler OC, Oymak E, Yazici G, Akagunduz OO, Cetinayak O, Erpolat P, Aksoy A, Duzova M, Yildirim BA, Kurt M, Canyilmaz E, Yavas G, Akyurek S, Oksuz DC, Saglam EK, Celik OK, Ozyar E, Cengiz M, Onal C) Oncol Res 2023;31(3):299-306 2 Citations |
| 2 | Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy. (Simone CB 2nd, Serebrenik AA, Gore EM, Mohindra P, Brown SL, Wang D, Chetty IJ, Vujaskovic Z, Menon S, Thompson J, Fine G, Kaytor MD, Movsas B) Int J Radiat Oncol Biol Phys 2024 Feb 01;118(2):404-414 12 Citations |
| 1 | Re-examining Post-operative Chemoradiotherapy in Head and Neck Cancer: An Updated Long-Term Combined Analysis of RTOG 9501/EORTC 22931 (Z.S. Zumsteg 1, M. Luu 2, C. Fortpied 3, J.K. Jang 1, M.M. Chen 4, J. Mallen-St. Clair 5, E. Walgama 5, Q.T. Le 6, M. Machtay 7, S. Tribius 8, A. Forastiere 9, S. Wong 10, E. Mahmut Ozsahin 11, V. Gregoire 12, J.B. Vermorken 13, A.S. Ho 6, S.S. Yom 14) Annals of Oncology |
| 1 | Re-examining post-operative chemoradiotherapy in head and neck cancer: an updated long-term combined analysis of RTOG 9501/EORTC 22931. (Zumsteg ZS, Luu M, Fortpied C, Jang JK, Chen MM, Mallen-St Clair J, Walgama E, Le QT, Machtay M, Tribius S, Forastiere A, Wong S, Ozsahin EM, Gregoire V, Vermorken JB, Ho AS, Yom SS) Ann Oncol 2025 Nov;36(11):1379-1388 4 Citations |
© 2026 Clinical & Translational Science Institute